NHF’s prestigious Medical and Scientific Advisory Council (MASAC) was
formed to issue recommendations and advisories on treatment, research and other
general health concerns of the coagulation disorders community. Since its inception
in 1954, MASAC has issued over 400 communications covering a wide range of
medical issues, from prevention and treatment to advocacy of continued research
initiatives. Each year, MASAC establishes standard treatment guidelines which
are often referred to by international experts, medical schools, pharmacists,
emergency room personnel, insurance companies and many others.
MASAC is composed of physicians, scientists and other medical professionals
with a wide range of expertise including coagulation disorders, blood safety
and infectious disease. Members of the community, as well as chairs of the
nursing, social work, and physical therapy working groups also serve on MASAC.
MASAC usually meets three times a year to issue recommendations which are then
forwarded to the NHF Board of Directors for approval.
To view a listing
of current MASAC documents, click here. The availability
of new MASAC documents is announced periodically in HemAware magazine and always
available through HANDI.